Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Biocides; animal or insect repellents or attractants
Reexamination Certificate
2002-08-26
2009-08-11
Padmanabhan, Sreeni (Department: 1617)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Biocides; animal or insect repellents or attractants
C514S579000
Reexamination Certificate
active
07572459
ABSTRACT:
To inhibit, prophylactically or therapeutically, a bacterial, yeast, fungal, or parasitic agent in a patient, an effective amount of a dendrimer is administered to the patient, which dendrimer has a plurality of terminal groups, at least one of which has an anionic- or cationic-moiety covalently bonded or linked thereto. The anionic-containing moiety is not a disaccharide or oligosaccharide moiety, and, where the anionic-containing moiety is a neuraminic- or sialic acid-containing moiety, it is modified in the 4-position by substitution with an amino, amido, cyano, azido or guanido group, or is unsaturated.
REFERENCES:
patent: 5527524 (1996-06-01), Tomalia et al.
patent: 5658574 (1997-08-01), Bahary et al.
patent: 5736533 (1998-04-01), Simon et al.
patent: 6190650 (2001-02-01), Matthews et al.
patent: 6464971 (2002-10-01), Matthews et al.
patent: WO 95/34595 (1995-12-01), None
patent: WO 97/14404 (1997-04-01), None
patent: WO 97/48711 (1997-12-01), None
patent: WO 98/26662 (1998-06-01), None
Essentials of Medical Microbiology, 5th ed. Volk et al, p. 650, Lippincot.
Somei Kojima, Immunoregulation and Parasitic Infections, 1997, FEMS Immunology and Medical Microbiology, vol. 18, pp. 319-324.
Mandell et al, Parasitic Infections: Therapeutic Considerations, 1988, Update on Antibiotics II, Medical Clinics of North America, vol. 72, No. 3, pp. 669-690.
Adel A. F. Mahmoud, Parasitic Protozoa and Helminths: Biological and Immunological Challenges, 1989, Science, vol. 246, No. 4933, pp. 1015-1022.
Mamoun et al, Transfer of Genes intoPlasmodium falciparumby Polyamidoamine Dendrimers, 1999, Molecular and Biochemical Parasitology, vol. 103, pp. 117-121.
Attia et al., “Interaction of Oligodeoxynucleotides with Mycobacteria: Implications for New Therapeutic Strategies,”Antisense and Nucleic Acid Drug Development, 1998, 8:207-214, Mary Ann Liebert, Inc.
Holan George
Matthews Barry Ross
Bent Stephen A.
Carter Kendra D
Foley & Lardner LLP
Padmanabhan Sreeni
Starpharma Pty Ltd.
LandOfFree
Anionic or cationic dendrimer antimicrobial or antiparasitic... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anionic or cationic dendrimer antimicrobial or antiparasitic..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anionic or cationic dendrimer antimicrobial or antiparasitic... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4062965